Largest ever study of genetics of common disease just got bigger

Apr 14, 2008

DNA samples from 120,000 people are to be analysed in a £30 million follow up to last year's Wellcome Trust Case Control Consortium (WTCCC), the largest ever study of the genetics behind common diseases. The seven-fold increase in the number of samples to be analysed will allow researchers to look at a 25 diseases as well as studying the genetics of learning in children and individuals' responses to statins.

Funded by the Wellcome Trust, this new series of genome-wide association studies will be one of the most ambitious initiatives ever undertaken, bringing together leading research groups from at least 60 institutions internationally (including over 20 from the UK). Over the next two years, working in collaboration with the WTCCC or independently, the research teams are expected to analyse as many as 120 billion pieces of genetic data in the search for the genes underlying diseases such as multiple sclerosis, schizophrenia and asthma.

Researchers will examine between 500,000 and 1 million variants (SNPs) per sample as well as a comprehensive set of copy number variants (CNVs). Both SNPs and CNVs are responsible of the individual variation in our genomes.

"We have now entered a new era of large-scale genetics unthinkable even a few years ago," says Professor Peter Donnelly from the University of Oxford, who will chair the consortium. "Breakthroughs in our understanding of the human genome and rapid advances in sequencing technology mean that we are able to do very powerful analysis much faster and on a vastly bigger scale than ever before."

When the results of the WTCCC were announced in 2007, it was seen as a major breakthrough for medical science and was selected as one of the scientific highlights of the year by a number of the most prestigious scientific journals, including Nature and The Lancet. It identified a number of new genes and regions of the human genome which increase people’s susceptibility to or protect them from particular diseases.

Dr Mark Walport, Director of the Wellcome Trust, says: “It is now possible to unlock the genetics of common diseases. Although genetics tells only part of the story of disease, it can provide valuable and often unexpected insights that offer the promise of developing new treatments for these often very complex diseases.”

The research has been made possible by advances in progress in improved understanding of human genome variants, pioneered by the Wellcome Trust Sanger Institute at Hinxton, Cambridge. The Institute will devote a large part of its high-throughput genotyping pipeline headed by Dr Panos Deloukas to test many of the DNA samples. Most of the data analysis will be undertaken at the Wellcome Trust Centre for Human Genetics, University of Oxford.

“The Sanger Institute is bringing the power of its skills in genetic analysis to tackle common disease, to provide leadership, expertise and resources where they can make a difference," says Professor Leena Peltonen, who was appointed Head of Human Genetics at the Wellcome Trust Sanger Institute last year. "Our redefined strategy and joint expertise of human genetics faculty will ensure we deliver yet more ground-breaking results in clinically relevant areas."

Source: Wellcome Trust

Explore further: Innovative 'genotype first' approach uncovers protective factor for heart disease

add to favorites email to friend print save as pdf

Related Stories

Molecular gate that could keep cancer cells locked up

4 hours ago

In a study published today in Genes & Development, Dr Christian Speck from the MRC Clinical Sciences Centre's DNA Replication group, in collaboration with Brookhaven National Laboratory (BNL), New York, ...

Taking great ideas from the lab to the fab

5 hours ago

A "valley of death" is well-known to entrepreneurs—the lull between government funding for research and industry support for prototypes and products. To confront this problem, in 2013 the National Science ...

SR Labs research to expose BadUSB next week in Vegas

5 hours ago

A Berlin-based security research and consulting company will reveal how USB devices can do damage that can conduct two-way malice, from computer to USB or from USB to computer, and can survive traditional ...

Recommended for you

Study clarifies parents as source of new disease mutations

8 hours ago

Scientists have long speculated that mosaicism – a biological phenomenon, in which cells within the same person have a different genetic makeup – plays a bigger role in the transmission of rare disease mutations than ...

How black truffles deal with the jumpers in their genome

18 hours ago

The black truffle uses reversible epigenetic processes to regulate its genes, and adapt to changes in its surroundings. The 'methylome' - a picture of the genome regulation taking place in the truffle, is published in the ...

Gene research targets scarring process

Jul 28, 2014

Scientists have identified three genes that may be the key to preventing scar formation after burn injury, and even healing existing scars.

User comments : 0